ArticleJournal of clinical and experimental hepatology
A Case of First-line Atezolizumab Plus Bevacizumab Use in Recurrence of Combined Hepatocellular Cholangiocarcinoma After Surgical Resection.
Gordon T Moffat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.